Health technology assessments and pharmaceutical pricing
By Dr Wolfgang A Rehmann and Diana Heimhalt
Pharmaceutical benefit assessments play an increasingly important role in refunds by the national health services. In most European countries, a drug has to successfully pass a post-approval benefit evaluation before it becomes available in the publicly funded healthcare system. Most European member states have implemented health technology assessments-based pharmaceutical evaluation schemes; their results form the basis for pharmaceutical pricing.
The EU member states maintain different pricing systems. There are basically two variations…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
Insolvency proceedings were opened in respect of the assets of a German resident; the liquidator then sought to set aside a transaction that had been entered into with a resident of Switzerland.
As of 1 October 2012, transfers of majority shares in a private limited liability company in Slovakia have become more complicated.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town